The Systematic Production of Cells for Cell Therapies

被引：201

作者：

Kirouac, Daniel C. ^{[1
]}

Zandstra, Peter W. ^{[1
,2
,3
,4
]}

机构：

[1] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3E1, Canada

[2] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada

[3] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E1, Canada

[4] Univ Hlth Network, McEwen Ctr Regenerat Med, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON M5G 1L7, Canada

来源：

CELL STEM CELL | 2008年 / 3卷 / 04期

基金：

加拿大自然科学与工程研究理事会;

关键词：

D O I：

10.1016/j.stem.2008.09.001

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

Stem cells have emerged as the starting material of choice for bioprocesses to produce cells and tissues to treat degenerative, genetic, and immunological disease. Translating the biological properties and potential of stem cells into therapies will require overcoming significant cell-manufacturing and regulatory challenges. Bioprocess engineering fundamentals, including bioreactor design and process control, need to be combined with cellular systems biology principles to guide the development of next-generation technologies capable of producing cell-based products in a safe, robust, and cost-effective manner. The step-wise implementation of these bioengineering strategies will enhance cell therapy product quality and safety, expediting clinical development.

引用

页码：369 / 381

页数：13

共 138 条

[1] Functional immobilization of signaling proteins enables control of stem cell fate [J].

Alberti, Kristin ;

Davey, Ryan E. ;

Onishi, Kento ;

George, Sophia ;

Salchert, Katrin ;

Seib, F. Philipp ;

Bornhaeuser, Martin ;

Pompe, Tilo ;

Nagy, Andras ;

Werner, Carsten ;

Zandstra, Peter W. .

NATURE METHODS, 2008, 5 (07) :645-650

[2] Physicochemical modelling of cell signalling pathways [J].

Aldridge, Bree B. ;

Burke, John M. ;

Lauffenburger, Douglas A. ;

Sorger, Peter K. .

NATURE CELL BIOLOGY, 2006, 8 (11) :1195-1203

[3]

[Anonymous], 2004, GUIDANCE IND 5 FRAME

[4]

[Anonymous], 2007, ADV TECHNOLOGIES BIO

[5]

[Anonymous], 2005, ICH HARM TRIP GUID Q

[6] Common and distinct features of cytokine effects on hematopoietic stem and progenitor cells revealed by dose-response surface analysis [J].

Audet, J ;

Miller, CL ;

Eaves, CJ ;

Piret, JM .

BIOTECHNOLOGY AND BIOENGINEERING, 2002, 80 (04) :393-404

[7] Mathematical modeling and analysis in biochemical engineering: Past accomplishments and future opportunities [J].

Bailey, JE .

BIOTECHNOLOGY PROGRESS, 1998, 14 (01) :8-20

[8] Soluble factor cross-talk between human bone marrow-derived hematopoietic and mesenchymal cells enhances in vitro CFU-F and CFU-O growth and reveals heterogeneity in the mesenchymal progenitor cell compartment [J].

Baksh, D ;

Davies, JE ;

Zandstra, PW .

BLOOD, 2005, 106 (09) :3012-3019

[9] A non-contact suspension culture approach to the culture of osteogenic cells derived from a CD49elow subpopulation of human bone marrow-derived cells [J].

Baksh, Dolores ;

Zandstra, Peter W. ;

Davies, John E. .

BIOTECHNOLOGY AND BIOENGINEERING, 2007, 98 (06) :1195-1208

[10] The impact of progenitor enrichment, serum, and cytokines on the ex vivo expansion of mobilized peripheral blood stem cells: A controlled trial [J].

Balducci, E ;

Azzarello, G ;

Valenti, MT ;

Capuzzo, GM ;

Pappagallo, GL ;

Pilotti, I ;

Ausoni, S ;

Bari, M ;

Rosetti, F ;

Sartori, D ;

Ciappa, A ;

Porcellini, A ;

Vinante, O .

STEM CELLS, 2003, 21 (01) :33-40

← 1 2 3 4 5 6 7 8 9 10 →